482 related articles for article (PubMed ID: 20661746)
1. Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response.
Wu Z; Nagano I; Asano K; Takahashi Y
Parasitol Res; 2010 Oct; 107(5):1173-88. PubMed ID: 20661746
[TBL] [Abstract][Full Text] [Related]
2. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
3. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
[TBL] [Abstract][Full Text] [Related]
4. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
[TBL] [Abstract][Full Text] [Related]
5. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.
Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X
Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
[TBL] [Abstract][Full Text] [Related]
8. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis.
Okuda Y; Sakoda S; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T
J Neuroimmunol; 1999 Nov; 101(2):188-96. PubMed ID: 10580801
[TBL] [Abstract][Full Text] [Related]
9. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.
Serada S; Fujimoto M; Mihara M; Koike N; Ohsugi Y; Nomura S; Yoshida H; Nishikawa T; Terabe F; Ohkawara T; Takahashi T; Ripley B; Kimura A; Kishimoto T; Naka T
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9041-6. PubMed ID: 18577591
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
11. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
12. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
13. Blockade of tumour necrosis factor-α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology.
Batoulis H; Recks MS; Holland FO; Thomalla F; Williams RO; Kuerten S
Clin Exp Immunol; 2014 Jan; 175(1):41-8. PubMed ID: 24111507
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
[TBL] [Abstract][Full Text] [Related]
15. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH
Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380
[TBL] [Abstract][Full Text] [Related]
16. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
17. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis.
Thakker P; Leach MW; Kuang W; Benoit SE; Leonard JP; Marusic S
J Immunol; 2007 Feb; 178(4):2589-98. PubMed ID: 17277169
[TBL] [Abstract][Full Text] [Related]
18. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.
Jäger A; Dardalhon V; Sobel RA; Bettelli E; Kuchroo VK
J Immunol; 2009 Dec; 183(11):7169-77. PubMed ID: 19890056
[TBL] [Abstract][Full Text] [Related]
19. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis.
Marusic S; Leach MW; Pelker JW; Azoitei ML; Uozumi N; Cui J; Shen MW; DeClercq CM; Miyashiro JS; Carito BA; Thakker P; Simmons DL; Leonard JP; Shimizu T; Clark JD
J Exp Med; 2005 Sep; 202(6):841-51. PubMed ID: 16172261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
